Insurancenewsnet.com

Sources Sought Notice – Q– Maintenance Agreement for MEDRAD’s Spectris Solaris & MEDRAD’s Stellant CT Injection System

(2). Scope of Work: The Contractor shall provide all resources necessary to accomplish the deliverables described in this statement of work (SOW), except as may otherwise be specified. (3). Background ...
Business Wire

Global Contrast Injectors Market 2020-2024 | Evolving Opportunities with Bayer AG and Bracco Spa | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
Nasdaq

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Joplin Globe

Bayer’s Receives FDA Clearance for MEDRAD® Centargo CT Injection System

Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...